Table 3 Generation of D3CO-substituted arenes from triazene resins
in CD3OD
Scheme 2 Combination of protocols: synthesis of arenes with
deuterium and OCD3 substitution. (a) Pd/C, H2, MeOH, rt, 12 h,
(b) i. C5H11ONO, BF3ÁEt2O, THF, À20 1C; ii. pyridine, MeCN,
benzylamine resin, À20 1C–rt, 12 h.
No Resin R1
R2
R3
Br
R4
H
Yield [%]
carbonyl residues. By using methanol-d4, the cost-effectiveness
of the reaction can be improved in the case of electron-rich arenes.
Starting with the same triazene linker system, we also developed a
high-yielding method for the preparation of trideuterated
compounds. Without precedent, the synthesis of D3CO-bearing
derivatives in the presence of carboxylic acids and alcohols was
achieved independently of the use of toxic methylating agents.
Lastly, we have demonstrated that a combination of the methods
described herein can even be used for the synthesis of arenes
displaying more than one deuterium substitution.
1
2
3
4
5
6
7
8
9
1l
1m
1r
1s
1t
1u
1v
1w
1x
–CHCHCHCH–
H
H
Ph
H
56
55
71
76
51
52
36
H
H
H
Ar (p-OMe) H
Ph
H
H
H
H
H
H
CH2OH H
H
H
OMe
Cl
Me
Me
COCH3
H
H
H
H
H
H
Me
D
H
H
I
OMe
H
CO2Me 73 (82)a
H
H
H
H
H
62
44
10 1y
11 1z
12 1aa
36
Ph
H
79b
80b
t
13 1ab CHCHCO2 Bu H
Notes and references
a
b
Yields in brackets refer to syntheses in the mmol scale. Syntheses in
solution.
1 (a) M. R. Moeller, P. Fey and R. Wennig, Forensic Sci. Int., 1993,
63, 185–206; (b) A. F. Fentiman Jr and R. L. Foltz, J. Labelled
Compd. Radiopharm., 1976, 12, 69–78.
2 (a) K. Sanderson, Nature, 2009, 458, 269; (b) T. Agres, Drug
Discovery Dev., 2009, 12, 6–8.
3 (a) T. D. Nguyen, G. Hukic-Markosian, F. Wang, L. Wojcik,
X.-G. Li, E. Ehrenfreund and Z. V. Vardeny, Nat. Mater., 2010, 9,
345–352; (b) C. C. Tong and K. C. Hwang, J. Phys. Chem., 2007,
111, 3490–3494.
4 (a) C. O’Driscoll, Chem. Ind., 2009, 9, 24–26; (b) H. J. Altermatt,
J. O. Gebbers, W. Arnold and J. A. Laissue, Laryngo-Rhino-Otologie,
1987, 66, 191–194.
5 D. M. LeMaster, Annu. Rev. Biophys. Biophys. Chem., 1990, 19,
243–266.
in the presence of existing methoxy groups, or of benzoic acids or
alcohol functionalities without side reactions, which renders the
method a highly attractive possibility for a selective labeling
protocol. The D3CO-generating cleavage protocol has been
verified on the mmol scale as well, giving the target molecule 4w
(entry 8, Table 3) in a comparable yield. The D3CO-introduction
has been shown in solution as well. For this reason, we synthesized
triazenes with the diisopropylamino backbone, furnishing target
substances (4aa and 4ab, entries 12 and 13, Table 3) in 79% and
80% yields, respectively.
6 (a) R.-J. Roe, Methods of X-ray and neutron scattering in
polymer science, Oxford, New York, 2000, ch. 6, pp. 228–235;
(b) F. Meilleur, K. L. Weiss and D. A. A. Myles, Methods Mol.
Biol., 2009, 544, 281–292.
To emphasize the scope of the deutero-dediazoniation protocols
presented herein, we applied our methodology to the synthesis
of arenes with a twofold deuterium-substitution. Resin 1j was
re-synthesized on the gram scale and subsequently reacted
according to general procedure 8 (see ESIw GP8) to give
deuterated nitroarene 3j. After conversion into the corres-
ponding amine and immobilization on benzylamino resin (to
give 1z), the dediazoniation could be applied again success-
fully. In this particular case, due to the absence of an ortho-
ether functionality, the reaction yields over two steps the
D3CO-substituted compound 4z in 36% yield (see Scheme 2).
The herein presented methods for the synthesis of compounds
with deuterium- and D3CO-substitution simplify the generation of
deuterated compounds and offer a new effective, non-toxic, mild
reaction pathway to those substrates. Initially developed with the
small scale synthesis of deuterated building blocks for the forma-
tion of libraries in mind, the methodology proved to be readily
scalable to a mmol scale, yielding the target substrates in high
yields with a minimum of preparative effort. The methodology for
monodeuteration in THF-d8, including the cleavage procedure, is
both high yielding and substituent-independent, allowing for the
first time the selective introduction of deuterium in arenes in the
presence of functionalities such as halogen substituents and
7 P. C. Painter, M. M. Coleman and J. L. Koenig, The Theory of
Vibrational Spectroscopy and Its Application to Polymeric Materials,
John Wiley, New York, 1982.
8 (a) K. B. Wiberg, Chem. Rev., 1955, 55, 713–743; (b) J. Reuben,
J. Am. Chem. Soc., 1986, 108, 1735–1738; (c) D. Wade, Chem.-Biol.
Interact., 1999, 117, 191–217 and references therein.
9 S. Lu, W.-W. Li, D. Rotem, E. Mikhailova and H. Bayley, Nat.
Chem., 2010, 2, 921–928.
10 (a) L. R. Pohl and J. R. Gillette, Drug Metab. Rev., 1984–1985, 15,
1335–1351; (b) A. B. Foster, Trends Pharmacol. Sci., 1984, 5,
524–527; (c) K. C. Buteau, J. High Technol. Law, 2009, 10, 22–74.
11 For example, Concert Pharmaceuticals or Protia.
12 Review: (a) F. Alonso, I. P. Beletskaya and M. Yus, Chem. Rev.,
2002, 102, 4009–4091; (b) T. Junk and W. J. Catallo, Chem. Soc.
Rev., 1997, 26, 401–406.
13 S. P. Markey, K. Powers, D. Dubinsky and I. J. Kopin, J. Labelled
Compd. Radiopharm., 1980, 17, 103–114.
15 R. H. Liu, S. M. Wang and D. V. Canfield, Quantitation and mass
spectrometric data of drugs and isotopically labeled analogs, CRC
Press, Boca Raton, FL, 2009.
16 T. Shono, Y. Matsumura and K. Tsubata, Chem. Lett., 1979, 1051–1054.
17 F. W. Wassmundt and W. F. Kiesman, J. Labelled Compd.
Radiopharm., 1995, 36, 281.
18 S. Brase, D. Enders, J. Kobberling and F. Avemaria, Angew. Chem.,
¨
¨
1998, 110, 3614–3616 (Angew. Chem., Int. Ed., 1998, 37, 3413–3415).
19 H. Zollinger, Angew. Chem., 1978, 90, 151–160 (Angew. Chem., Int.
Ed. Engl., 1978, 17, 141–150).
c
This journal is The Royal Society of Chemistry 2011
Chem. Commun., 2011, 47, 9063–9065 9065